
3M Company
MMM3M Company (MMM) is a multinational conglomerate known for its diversified product portfolio, including adhesives, abrasives, healthcare products, and consumer goods. Founded in 1902, the company has a long history of innovation and is recognized for developing numerous technological solutions across various industries such as healthcare, automotive, electronics, and consumer markets. 3M operates globally and is committed to advancements in sustainability and safety.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 12, 2026 | $0.78 | 2026-05-22 | 2026-05-22 |
| March 12, 2026 | $0.78 | 2026-02-13 | 2026-02-13 |
| December 12, 2025 | $0.73 | 2025-11-14 | 2025-11-14 |
| September 12, 2025 | $0.73 | 2025-08-25 | 2025-08-25 |
| June 12, 2025 | $0.73 | 2025-05-23 | 2025-05-23 |
Dividends Summary
- Consistent Payer: 3M Company has rewarded shareholders with 90 dividend payments over the past 22 years.
- Total Returned Value: Investors who held MMM shares during this period received a total of $79.83 per share in dividend income.
- Latest Payout: The most recent dividend of $0.78/share was paid 36 days ago, on June 12, 2026.
- Yield & Schedule: MMM currently pays dividends quarterly with an annual yield of 1.89%.
- Dividend Growth: Since 2004, the dividend payout has grown by 116.7%, from $0.36 to $0.78.
- Dividend Reliability: MMM has maintained or increased its dividend for 9 consecutive payments.
Company News
The global reactive hot melt adhesives market is expected to grow at a CAGR of 7.72% from 2025 to 2035, driven by VOC emission regulations replacing solvent-based adhesives, automotive lightweighting demands for multi-substrate bonding, and increased adoption in furniture and industrial applications. Polyurethane adhesives dominate with 48% marke...
The global health and safety management market is projected to grow from $2.07 billion in 2026 to $2.87 billion by 2030, with a compound annual growth rate of 8.5%. Growth is driven by rising workplace accidents, regulatory pressure, and adoption of AI-powered risk prediction, IoT monitoring, cloud-based compliance platforms, and automated safety...
Sweden's flu diagnostic and treatment market is projected to grow from USD 172.1 million in 2026 to USD 210.3 million by 2031 at a 4.1% CAGR, driven by high influenza burden among elderly populations and increased adoption of molecular diagnostics and targeted antiviral therapies. The market operates within Sweden's centralized healthcare system ...
The global pharmaceutical filtration market is expected to grow at a CAGR of 8.13% from 2025 to 2034, driven by rising biopharmaceutical demand, CDMO expansion, and increased sterile drug manufacturing. North America leads the market, while Asia-Pacific emerges as a rapidly growing region. Major players are investing in capacity expansion and acq...
The global sterile bioprocess filtration market is projected to grow from USD 6.50 billion in 2025 to USD 31.33 billion by 2034, at a CAGR of 19.13%. Growth is driven by rising biopharmaceutical and vaccine demand, outsourcing to CMOs/CDMOs, and technological advancements. North America is expected to lead the market, with membrane filters domina...








